Vijesti
- BIOGEN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Biogen, Inc. in the United States District Court for the District of Massachusetts
18.02.2022 / 15:57 - GlobeNewswire
-
- Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic Alternatives
17.02.2022 / 14:00 - GlobeNewswire
-
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
17.02.2022 / 03:44 - GlobeNewswire
-
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys About Lead Plaintiff Opportunity in Securities Class Action
14.02.2022 / 15:37 - GlobeNewswire
-
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Telos, Fennec, and Astra Space and Encourages Investors to Contact the Firm
14.02.2022 / 03:00 - GlobeNewswire
-
- HAGENS BERMAN BIIB ALERT: Investors in Biogen Inc. (BIIB) With Significant Losses Have Opportunity to Lead Securities Class Action
09.02.2022 / 02:11 - GlobeNewswire
-
- Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
08.02.2022 / 14:00 - GlobeNewswire
-
- BioCryst Appoints Machelle Sanders to Board of Directors
08.02.2022 / 13:00 - GlobeNewswire
-
- Vir Biotechnology Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global
08.02.2022 / 12:00 - GlobeNewswire
-
- Block & Leviton LLP Has Filed a Lawsuit Against Biogen, Inc. for Securities Law Violations
08.02.2022 / 00:04 - GlobeNewswire